EGLN2 and obesity disorder: As expected, WT mice developed obesity, hepatic steatosis and systemic insulin resistance when fed a HFD, and the extent of these diet-induced metabolic dysfunctions was found to be similar in PHD1−/− mice despite higher baseline body weight and insulin-resistance on standard chow diet.